Manufacturing and banking of mesenchymal stem cells
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Mesenchymal stem cells (MSC) and MSC-like cells hold great promise and offer many advantages for developing effective cellular therapeutics. Current trends indicate that the clinical application of MSC will continue to increase markedly. For clinical applications, large numbers of MSC are usually required, ideally in an off-the-shelf format, thus requiring extensive MSC expansion ex vivo and subsequent cryopreservation and banking. AREAS COVERED: To exploit the full potential of MSC for cell-based therapies requires overcoming significant cell-manufacturing, banking and regulatory challenges. The current review will focus on the identification of optimal cell source for MSC, the techniques for production scale-up, cryopreservation and banking and the regulatory challenges involved. EXPERT OPINION: There has been considerable success manufacturing and cryopreserving MSC at laboratory scale. Surprisingly little attention, however, has been given to translate these technologies to an industrial scale. The development of cost-effective advanced technologies for producing and cryopreserving commercial-scale MSC is important for successful clinical cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 15×
“Similarly, SVMSC and AT-MSC displayed a high potential for adipogenic differentiation [31], whereas CB-MSC did not [25].”
BackgroundResultInfluentialAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Consequently, one practical issue to consider for clinical banking is the development of large-scale manufacturing methods with appropriate quality assurance and quality control [2,3].”
BackgroundBaksh, D., Yao, R., & Tuan, R. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0709 · Cited by 1,058
Schwarz, R. P., Goodwin, T. J., & Wolf, D. A. (1992) · Journal of Tissue Culture Methods · doi:10.1007/bf01404744 · Cited by 399 · cited 1×
“There are other bioreactor configurations that are sporadically used for human MSC culture expansion, such as rotating wall vessel bioreactors in which cells are suspended in simulated microgravity with negligible mechanical hydrodynamic shear force but with a high mass transfer of nutrients, and perfusion-based biore…”
BackgroundComparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Cartilage, and Adipose Tissue
Peng, L., Jia, Z., Yin, X., Zhang, X., Liu, Y., Chen, P., Ma, K., & Zhou, C. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0217 · Cited by 368 · cited 1×
“This wave of increased attention toward other tissue sources resulted in the characterization of several tissue-specific MSC which have been systematically evaluated against bone marrow as the gold standard [22-26].”
BackgroundScalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264 · cited 1×
“Among the most extensively used suspension bioreactor types on a laboratory scale are spinner flasks, whereas on a mass scale stirred suspension bioreactor systems are utilized [50,56].”
The Origins of Mesenchymal Stromal Cell Heterogeneity
Pevsner-Fischer, M., Levin, S., & Zipori, D. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9229-7 · Cited by 251 · cited 2×
“This inter-population heterogeneity could be ascribed to the fact that different stages of MSC may exist within the stem cell niche or may be due to the plasticity of mesenchymal phenotype and extended culturing ex vivo [46].”
BackgroundContaminated liquid nitrogen vapour as a risk factor in pathogen transfer
Grout, B. W. W., & Morris, G. J. (2009) · Theriogenology · doi:10.1016/j.theriogenology.2008.12.011 · Cited by 95 · cited 1×
“LN2 has also been shown to act as a vehicle for the transmission of viruses, bacteria and fungi both in liquid and vapor phases and can yield cross-contamination [122,123].”
Background
Cited by
Human mesenchymal stem cells - current trends and future prospective
Ullah, I., Subbarao, R. B., & Rho, G. J. (2015) · Bioscience Reports · doi:10.1042/bsr20150025 · Cited by 1,337
Synthetic alternatives to Matrigel
Aisenbrey, E. A., & Murphy, W. L. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0199-8 · Cited by 1,016
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E., & Elliott, J. A. W. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.07.003 · Cited by 346
“Tremendous research, regulatory and industrial resources have been expended towards optimizing the protocols, freezing media composition, cooling devices and storage containers in order to ensure that MSCs retain their therapeutic characteristics after freeze/thaw [95,193].”
BackgroundHuman umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy
Li, T., Xia, M., Gao, Y., Chen, Y., & Xu, Y. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1051528 · Cited by 263
Metadata
- Authors
- Thirumala, S., Goebel, W. S., & Woods, E. J.
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-01-23
- Volume
- 13
- Issue
- 5
- Pages
- 673-691
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2115635465
- Cited by
- 95
- References
- 8
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Manufacturing and banking of mesenchymal stem cells. https://app.cochat.ai/papers/10.1517/14712598.2013.763925
- The paper
- Thirumala, S., Goebel, W. S., & Woods, E. J. (2013). Manufacturing and banking of mesenchymal stem cells. Expert Opinion on Biological Therapy. https://doi.org/10.1517/14712598.2013.763925
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.